CS logo
small CS logo
Women's Specialty Center

Jackson, Mississippi, United States
Gynecologist in Jackson, Mississippi
501 Marshall St #600, Jackson, MS 39202

About Women's Specialty Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
1
Unither Pharmaceuticals
1
Total Rows: 2

Clinical Trials at Women's Specialty Center


During the past decade, Women's Specialty Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trial for Ovarian Cancer (OvaRex®)
2002-12-01
2007-12-01
Terminated
354
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
2011-05-01
2012-05-01
Completed
990

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 1Pfizer: 1Unither Pharmaceuticals: 1Unither Pharmaceuticals: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Women's Specialty Center


According to Clinical.Site data, the most researched conditions in "Women's Specialty Center" are "Ovarian Cancer" (1 trials) and "Urinary Bladder, Overactive" (1 trials). Many other conditions were trialed in "Women's Specialty Center" in a lesser frequency.

Clinical Trials Intervention Types at Women's Specialty Center


Most popular intervention types in "Women's Specialty Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Fesoterodine 8 mg" (1 trials), "Placebo" (1 trials) and "oregovomab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Women's Specialty Center


The vast majority of trials in "Women's Specialty Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Women's Specialty Center


Currently, there are NaN active trials in "Women's Specialty Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Women's Specialty Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Women's Specialty Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Terminated: 1Terminated: 1